1. Home
  2. ORN vs TRDA Comparison

ORN vs TRDA Comparison

Compare ORN & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

HOLD

Current Price

$11.86

Market Cap

415.4M

Sector

Industrials

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$12.49

Market Cap

438.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORN
TRDA
Founded
1994
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
415.4M
438.8M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
ORN
TRDA
Price
$11.86
$12.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$16.25
$20.00
AVG Volume (30 Days)
423.3K
189.4K
Earning Date
06-15-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
220.00
N/A
EPS
0.06
N/A
Revenue
$852,260,000.00
$25,421,000.00
Revenue This Year
$7.08
$51.37
Revenue Next Year
$9.52
$46.98
P/E Ratio
$197.33
N/A
Revenue Growth
7.01
N/A
52 Week Low
$4.64
$4.93
52 Week High
$15.00
$12.93

Technical Indicators

Market Signals
Indicator
ORN
TRDA
Relative Strength Index (RSI) 37.25 59.20
Support Level $8.18 $9.59
Resistance Level $13.17 $12.56
Average True Range (ATR) 0.86 0.84
MACD -0.31 0.06
Stochastic Oscillator 13.17 82.55

Price Performance

Historical Comparison
ORN
TRDA

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: